A digital dawn for diabetes: how data can transform patient care - Industry Symposium Supported by Novo Nordisk

Session Description:

During this symposium we will discuss the potential for digital health, focusing on smart pen technology, in helping overcome challenges for patients and HCPs in achieving glycaemic control. The Chair, Søren Smed Østergaard (Novo Nordisk), will lead us through an exciting programme of scientific presentations followed by expert panel discussions, including patient insights, to help frame the scientific data in a real-world context with the opportunity for questions from the audience. Professor Richard Bergenstal will overview barriers to glycaemic control and introduce some of the potential digital health solutions such as smart pen technology followed by a panel discussion. After, Professor Bergenstal will continue by examining the clinical evidence for the use of smart pens focusing on data on time-in-range and insulin treatment adherence before the second panel discussion looking at the realities of managing diabetes with aid of smart pen technology. Finally, Dr Peter Adolfsson will look into the future to examine how digital health and the increased availability of patient data could help drive a more personalized approach to care. The symposium will close with a panel discussion reflecting on the future of digital health and the opportunities to help improve outcomes for people with diabetes. During the panel discussions we will also be joined by Dr Markus Menzen to provide his clinical insights on digital health.